| Literature DB >> 26283896 |
Julien Brechbühl1, Fabian Moine1, Monique Nenniger Tosato1, Frank Sporkert2, Marie-Christine Broillet1.
Abstract
In the wild, animals have developed survival strategies relying on their senses. The individual ability to identify threatening situations is crucial and leads to increase in the overall fitness of the species. Rodents, for example have developed in their nasal cavities specialized olfactory neurons implicated in the detection of volatile cues encoding for impending danger such as predator scents or alarm pheromones. In particular, the neurons of the Grueneberg ganglion (GG), an olfactory subsystem, are implicated in the detection of danger cues sharing a similar chemical signature, a heterocyclic sulfur- or nitrogen-containing motif. Here we used a "from the wild to the lab" approach to identify new molecules that are involuntarily emitted by predators and that initiate fear-related responses in the recipient animal, the putative prey. We collected urines from carnivores as sources of predator scents and first verified their impact on the blood pressure of the mice. With this approach, the urine of the mountain lion emerged as the most potent source of chemical stress. We then identified in this biological fluid, new volatile cues with characteristic GG-related fingerprints, in particular the methylated pyridine structures, 2,4-lutidine and its analogs. We finally verified their encoded danger quality and demonstrated their ability to mimic the effects of the predator urine on GG neurons, on mice blood pressure and in behavioral experiments. In summary, we were able to identify here, with the use of an integrative approach, new relevant molecules, the pyridine analogs, implicated in interspecies danger communication.Entities:
Keywords: GC-MS analysis; Grueneberg ganglion; HS-SPME; behavior; blood pressure; calcium imaging; olfaction; predator scents
Year: 2015 PMID: 26283896 PMCID: PMC4517376 DOI: 10.3389/fnins.2015.00253
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Figure 1Screening of predator urines via tail-cuff analysis. The blood pressure of mice is analyzed by tail-cuff measurements. (A) Mice are placed on the tail-cuff platform, which is connected to a control unit and a computer. They are maintained in magnetic restrainers and their tails are placed in the cuff/pulse optical sensor. Details of the experimental procedure are shown; the blotting paper (tested cues), the inflatable balloon (tail pressure control) and the fixation of the tail with adhesive tape. (B) The system is tested here with 1% TMT (synthetic red fox kairomone), which significantly increases the mice blood pressure. (C,D) Examples of one measurement for the diastolic and the systolic pressures performed on the same mouse under control conditions (C, Ctrl) or test conditions, here exposed to the pure urine of the mountain lion (D, Mt. Lion). Oscillating waveforms are obtained according to the automatic analysis of the photoplethysmographic signal detected by the pulse sensors [red LED in (A)]. Waveform amplitudes are indicated by arbitrary units (a.u.). The mean pressure is calculated as the mean between the diastolic and the systolic pressures. (E–M) Tests of different carnivore urines (E–H, Felidae; I–K, Canidae), non-carnivore urine (L, Bison) or only water (M, Water). Exposure to the urine of the Mt. Lion induced the most significant increase in mice blood pressure (E). Control conditions (white bars) and test sessions (black bars) are shown (B–M). Five adult male mice were used (B,E–M). Values are expressed as mean ± SEM; one-tailed paired t-test or w-test, *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant.
HS-SPME/GC-MS analysis of the urine of the mountain lion.
| 2.141 | 1 | 1-Propanol | Propyl alcohol |
| 4.254 | 2 | 3-Buten-1-ol, 3-methyl- | Isoprenol |
| 4.678 | 3 | 1,2-Propanediol | Propylene glycol |
| 4.775 | 4 | 1H-Pyrrole | – |
| 5.314 | 5 | 2-Buten-1-ol, 3-methyl- | Prenol |
| 5.870 | – | Unidentified compound | – |
| 6.304 | 6 | Pyridine, 4-methyl- | 4-Picoline |
| 6.450 | 7 | Pyrazine, 2-methyl- | – |
| 6.617 | 8 | 2-Pentenal, 2-methyl- | – |
| 6.728 | 9 | Ethanol, 2-(methylthio)- | – |
| 6.989 | 10 | Cyclopentanone, 3-methyl- | – |
| 7.069 | 11 | Thiazole | – |
| 7.149 | 12 | 1-Hexanol | Hexyl alcohol |
| 7.409 | – | Unidentified compound | – |
| 7.489 | 13 | Pyridine, 2,6-dimethyl- | 2,6-Lutidine |
| 7.531 | 14 | 3-Heptanone | Butyl ethyl ketone |
| 7.590 | 15 | Methane, bis(methylthio)- | 2,4-Dithiapentane |
| 7.743 | 16 | Oxime-, methoxy-phenyl- | – |
| 8.084 | 17 | Pyrazine, 2,6-dimethyl- | – |
| 8.195 | 18 | 1H-Pyrrole, 2,5-dimethyl- | – |
| 8.285 | 19 | Pyridine, 2,4-dimethyl- | 2,4-Lutidine |
| 8.525 | 20 | 1-Butanamine, N-butyl- | Dibutylamine |
| 8.674 | 21 | Pyridine, 2-ethyl-6-methyl | 2-Picoline, 6-ethyl- |
| 8.754 | 22 | Pyridine, 3,4-dimethyl- | 3,4-Lutidine |
| 8.845 | 23 | Cyclopentanone, 3-ethyl- | – |
| 9.144 | 24 | 2-Octanone | – |
| 8.942 | 25 | Phenol | – |
| 9.171 | 26 | 1H-Pyrrole, 2,3,5-trimethyl- | – |
| 9.266 | 27 | Pyrazine, 2-ethyl-6-methyl- | – |
| 9.338 | 28 | Pyrazine, 2-ethyl-5-methyl- | – |
| 9.415 | 29 | Pyrazine, 2,3,5-trimethyl - | – |
| 9.627 | – | Unidentified compound | – |
| 9.651 | 30 | Thiazole, 2-acetyl- | |
| 9.707 | 31 | Ethane, 1,2-bis(methylthio)- | 2,5-Dithiahexane |
| 9.821 | 32 | Pyrazine, 2-isopropyl-5-methyl- | – |
| 9.856 | 33 | Furan, 2-Acetyl-5-methyl- | – |
| 10.009 | 34 | Phenol, 2-methyl- | |
| 10.100 | – | Unidentified compound | – |
| 10.190 | – | Unidentified compound | – |
| 10.273 | 35 | Phenol, 4-methyl- | |
| 10.284 | 36 | Pyrazine, 3-ethyl-2,5-dimethyl- | – |
| 10.371 | 37 | Pyrazine, 2-ethyl-3,5-dimethyl- | – |
| 10.419 | 38 | Pyrazine, 2-methyl-3-propyl- | – |
| 10.489 | 39 | Pyrazine, 2-methyl-5-propyl- | – |
| 10.694 | – | Unidentified compound | – |
| 10.795 | 40 | Thiazole, 2-acetyl-4-methyl- | – |
| 10.909 | 41 | Pyrazine, 2-methyl-6-propyl- | – |
| 10.965 | 42 | 2-Propanone, 1-phenyl- | Phenylacetone |
| 10.986 | 43 | 1H-Pyrrole-2-carboxaldehyde, 3,4-dimethyl- | – |
| 11.014 | 44 | 2-Cyclohexen-1-one, 3,5,5-trimethyl- | Isophorone |
| 11.104 | 45 | Pyrazine, 2,3-diethyl-5-methyl- | – |
| 11.239 | 46 | Pyrazine, 2,5-dimethyl-3-propyl- | – |
| 11.333 | 47 | Pyrazine, 3,5-dimethyl-2-propyl- | – |
| 11.451 | – | Unidentified compound | – |
| 11.507 | – | Unidentified compound | – |
| 11.538 | 48 | Pyrazine, 2-acetyl-3,5-dimethyl- | – |
| 11.834 | – | Unidentified compound | – |
| 11.875 | 49 | Pyrazine, 2,5-diethyl-3,6-dimethyl- | – |
| 11.921 | – | Unidentified compound | – |
| 11.976 | – | Unidentified compound | – |
| 12.022 | 50 | Pyrazine, 2,3,5-trimethyl-6-propyl- | – |
| 12.077 | 51 | Pyrazine, 2,5-dimethyl-3-(1-propenyl)-, (Z)- | – |
| 12.119 | - | Unidentified compound | – |
| 12.136 | 52 | Benzothiazole | – |
| 12.160 | – | Unidentified compound | – |
| 12.220 | 53 | Pyrazine, 2-Isopropenyl-3,6-dimethyl- | – |
| 12.296 | – | Unidentified compound | – |
| 12.345 | – | Unidentified compound | – |
| 12.522 | 54 | Pyrazine, 2-methyl-3-propyl- | – |
| 12.657 | – | Unidentified compound | – |
| 12.800 | 55 | 1H-Indole | – |
| 13.015 | 56 | 3,3-dimethyl-4,5-dithiahexan-1-ol | – |
| 13.081 | – | Unidentified compound | – |
| 13.148 | – | Unidentified compound | – |
| 13.353 | 57 | Pyrazine, 3,6-dipropyl-2,5-dimethyl- | – |
| 13.429 | 58 | Pyrazine, 3-isopentyl-2,5-dimethyl- | – |
| 13.592 | 59 | Pyrazine, 2,6-dimethyl-3-(2-methyl-1-butyl)- | – |
| 13.634 | – | Unidentified compound | – |
| 13.707 | – | Unidentified compound | – |
| 13.822 | 60 | 1H-Benzimidazole, 2,5-dimethyl- | – |
| 13.864 | – | Unidentified compound | – |
| 13.923 | – | Unidentified compound | – |
| 13.978 | 61 | 5,9-Undecadien-2-one, 6,10-dimethyl-, (E)- | Geranyl acetone |
| 14.142 | – | Unidentified compound | – |
| 14.194 | – | Unidentified compound | – |
| 14.246 | – | Unidentified compound | – |
| 14.284 | – | Unidentified compound | – |
| 14.406 | – | Unidentified compound | – |
| 14.548 | – | Unidentified compound | – |
| 14.736 | – | Unidentified compound | – |
| 14.931 | – | Unidentified compound | – |
| 15.031 | – | Unidentified compound | – |
| 15.424 | – | Unidentified compound | – |
| 15.978 | – | Unidentified compound | – |
| 16.046 | – | Unidentified compound | – |
| 16.070 | – | Unidentified compound | – |
| 16.547 | – | Unidentified compound | – |
| 18.907 | – | Unidentified compound | – |
Volatiles from the urine of the mountain lion are listed according to their retention time (RT) expressed in minutes. Sixty-one referenced volatiles were detected in our experimental conditions. The identification number (ID), the chemical nomenclature (Molecule) and the usual name, if existing, of the identified molecules are mentioned. Detected compounds with no attributed name found in the Wiley7N or the NIST14 libraries are listed as “Unidentified compound.” Precise chemical identifications have been performed for the volatiles marked with dots
, otherwise they have been tentatively identified from the libraries.
Figure 2Identification of pyridine analogs as putative kairomones. (A) Representative part of a total ion chromatogram (TIC) of volatiles emitted from the urine of the mountain lion obtained by HS-SPME/GC-MS. Chemical formulas of a selection of volatiles are indicated above peaks with their affiliated ID number. When not mentioned as precise chemical identification (•), molecules have been tentatively identified by WileyN7/NIST14 mass spectral libraries. The 2,4-lutidine (2,4-Lu; ID19) is highlighted in red. (B–E) Detailed GC-MS analysis of the HS-SPME fiber extract. Here, the identification of the 2,4-lutidine is shown as an example. The mass charge ratio (m/z) value of 107 was used for the precise identification of the 2,4-lutidine (2,4-Lu) thanks to its retention time of 8.285 min (RT8.285) in the urine of the mountain lion (B, Mt. Lion) and for the synthetic 2,4-lutidine (B, Sy.). Experimental m/z spectrum (C, Exp. MS) is compared with the reference mass spectrum (D, Ref. MS) found in the WileyN7/NIST14 mass spectral libraries as well as with the corresponding mass spectrum of the synthetic cue (E, Sy. MS).
Figure 3Pyridine analogs are sufficient to mimic the systemic effects of predator urine in mice. (A) Coronal slice from the Grueneberg ganglion (GG) of an OMP-GFP mouse loaded with Fura-2AM. GG neurons (GGn) are localized between the nasal cavity (NC) and the nasal septum (NS). According to their intrinsic GFP fluorescence, GGn can be selected and observed either under Hoffman modulation view (Hv) or 380 nm in color-encoded map for unbound Fura. Here, a typical intracellular calcium increase induced by a control pulse of KCl (25 mM) observed before and at the peak in selected GGn (dashed rectangle). Scale bar, 10 μm in (A). (B) Representative continuous recording of a GGn responding to diluted urine of the mountain lion (Mt. Lion; 1:1000), to a set of pyrazines (2,6-dimethylpyrazine, 2,6-DMP; 2-ethyl-3,5-dimethylpyrazine, 2-EDMP; 2,3,5-trimethylpyrazine, 2,3,5-TMP; 100 μM) and to a set of pyridines (2,4-lutidine, 2,4-Lu; 3,4-lutidine, 3,4-Lu; 4-picoline, 4-Pi; 100 μM). (C–E) Examples of GGn with differential pattern of pyridine-evoked responses. (F) Proportion of responding GGn to the different tested cues. The Pyrazine mix (2,6-DMP, 2-EDMP, 2,3,5-TMP; 100 μM) and the Pyridine mix (2,4-Lu, 3,4-Lu, 4-Pi; 100 μM) were both able to initiate similar numbers of GGn responses comparable to the one observed with the diluted urine of the mountain lion (1:1000). A total of 60 viable GGn isolated from 6 mice (P1-7) were used (A–F). Fluorescence intensity Fura-2 ratio = F340/F380 is indicated by arbitrary units (a.u.); times are indicated by horizontal bars in (B–E). (G–I) Mice blood pressure analyzes by tail-cuff measurements for the Pyrazine mix (G), the Pyridine mix (H) or the 2,4-lutidine (I) at a dilution of 1%. Control conditions (white bars) and test sessions (black bars) are shown (G–I). Six adult male C57BL/6 mice were used (G–I). Values are expressed as mean ± SEM; one-tailed paired t-test or w-test, *P < 0.05; **P < 0.01; ns, not significant.
Figure 4Pyridine analogs generate stress-related behaviors in mice. An open field exploration test is used to evaluate the innate fear reactions of mice. (A) The behavioral arena observed during nocturnal phase. The limits of the arena zone (black rectangle) and the central zone (red dashed rectangle) are shown. Mice are automatically tracked (yellow circle) in the presence of different tested cues deposited on a blotting paper (blue square). Scale bar, 5 cm in (A). (B) Representative tracking distances covered by the same mouse in the presence of a neutral cue (Water), pure mountain lion urine (Mt. Lion), a mix of pyrazines (Pyrazine mix; 2,6-DMP, 2-EDMP, 2,3,5-TMP; 1%), a mix of pyridines (Pyridine mix; 2,4-Lu, 3,4-Lu, 4-Pi; 1%) or 2,4-lutidine (2,4-Lu; 1%). (C–G) Stress-related behaviors are quantified according to the control session and displayed as indexes. Stress (red) or non-stress (blue) tendencies are displayed on graphics. The number of visits in the central zone of the arena (C), the total walking distance recorded during 5 min (D), the defecation (number of fecal pellets) (E), the risk assessment episodes (F) and the freezing behaviors (G) were quantified. Innate fear reactions were observed for the mountain lion urine, the mixes of pyrazines and pyridines and for the 2,4-lutidine. Seven adult male mice were used (C–G). Values are expressed as mean ± SEM; one-tailed paired t-test or w-test, *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant.